Licensing is one of the safest, most effective ways to commercialize your MedTech IP — without building a company from scratch.

Watch the Free Workshop

Sign up for immediate access to the replay — free for MedTech innovators, inventors, and IP owners.

WS- MedTech Replay

No spam. No commitment. Unsubscribe anytime.

Free On-Demand Workshop · Instant Replay Access
MedTech IP Licensing Workshop

License Your MedTech IP to Partners Who Can Bring It to Market

Instead of facing the immense challenge of building a company from the ground up, discover how to partner with established healthcare businesses that have the funding, expertise, and distribution to commercialize your medical technology — and pay you royalties to do it.

$600B+Global MedTech market
3–7%Typical MedTech royalty range
ProvenGo-to-market strategy for IP owners
MedTech IP Licensing Workshop
About the Workshop

The Smarter Path to MedTech Commercialization

Building a medical technology company is extraordinarily capital-intensive, regulatory-heavy, and time-consuming. Most innovators underestimate what it takes — and run out of runway before reaching market.

Licensing offers a fundamentally different path. Partner with companies that already have FDA clearances, clinical relationships, sales infrastructure, and distribution — and let them pay you to bring your innovation to patients.

→
Skip the startup gauntlet.

Licensing lets you monetize your MedTech IP without raising capital, hiring a team, or navigating the full regulatory pathway on your own.

→
Partner with established players.

The right licensee already has the clinical relationships, reimbursement codes, and sales force your innovation needs to reach market.

→
Generate royalties — not just a one-time payout.

Structured licensing deals create ongoing royalty income that compounds as your partner scales — far more valuable than a flat IP sale.

→
Protect what you've built.

Properly structured agreements ensure you retain control of your IP while maximizing its commercial reach and royalty potential.

Why Licensing Works for MedTech

The MedTech Licensing Advantage

Medical technology has unique commercialization dynamics that make licensing not just viable — but often the optimal strategy for IP owners at every stage.

🏥

Access Established Distribution

Large MedTech companies have hospital relationships, GPO contracts, and sales infrastructure that would take years and millions to replicate independently.

📋

Leverage Partner Regulatory Expertise

FDA clearance is expensive and complex. The right licensing partner may already have pathways your innovation can fit into — dramatically reducing time to market.

💰

Maximize IP Value

Development stage, clinical evidence, and patent strength all affect your royalty rate. This workshop shows you how to position your IP to command the highest value.

🔁

Create Recurring Royalty Income

Unlike selling your IP outright, a licensing deal generates ongoing royalties — potentially for decades — tied to every unit sold or procedure performed.

⚡

Get to Market Faster

Partnering with a company that already has clearances, manufacturing, and sales channels can compress your time-to-market from years to months.

🛡️

Reduce Capital Risk

Licensing shifts the commercialization burden — and capital risk — to your partner. You focus on innovation; they focus on market execution.

Curriculum

What You'll Learn

Six focused sessions covering everything from MedTech IP fundamentals to running a successful licensing campaign and negotiating royalty rates.

01

MedTech IP Basics

A clear overview of patents, trademarks, trade secrets, know-how, and regulatory IP — what each is, how to protect it, and how each performs differently in licensing.

02

Smart IP Licensing Campaign Strategy

How to create, organize, and manage a MedTech licensing campaign — from identifying target licensees to structuring outreach and managing the process through close.

03

Bringing IP to Market — The Licensing Process

A step-by-step walkthrough of how a MedTech licensing deal moves from initial contact to signed agreement — including the stages most innovators never see coming.

04

Finding & Qualifying the Right Partner

What to look for in a MedTech licensing partner — strategic fit, market position, clinical capability, and financial strength — and how to qualify them before negotiating.

05

Royalties & Maximizing IP Value

How royalty rates are set in MedTech, what drives value in a licensing negotiation, and proven strategies for maximizing the total economic return on your IP.

06

Live Q&A — Your IP, Your Questions

A focused discussion with Rand Brenner about your specific IP and licensing situation — real answers to real questions from MedTech innovators and IP owners.

Who Should Attend

Built for MedTech Innovators

If you've developed medical technology and are evaluating how to commercialize it — without building an entire company — this workshop is directly relevant.

01

Medical Device Inventors

Independent inventors with patented or patent-pending medical device innovations looking for the fastest path to commercialization.

02

MedTech Startups

Early-stage companies with validated technology that want to scale through licensing partnerships rather than — or alongside — building a direct commercial operation.

03

Research Institutions & Universities

Technology transfer offices and research teams with medical innovations looking for structured commercialization through industry licensing partners.

04

Digital Health & Software IP Owners

Innovators in diagnostics, telehealth, clinical decision support, and healthcare software exploring licensing as a go-to-market strategy.

05

Healthcare Professionals With IP

Clinicians, surgeons, and healthcare practitioners who have developed patentable solutions to clinical problems and want to license them to device companies.

06

MedTech Advisors & Consultants

Professionals advising medical technology companies on commercialization strategy who want to add IP licensing to their toolkit.

Your Presenter

Learn From a Career Licensing Executive

Rand Brenner
IP Licensing Executive & Speaker

Rand Brenner

CEO, Licensing Consulting Group

Rand Brenner is President and CEO of Licensing Consulting Group, an IP consultancy specializing in strategic consulting, licensing management, and IP due diligence across medical technology, consumer products, entertainment, and regulated industries. He has an extensive career as both licensee and licensor, with a track record spanning multiple industries and major brand properties.

Rand is a professional speaker on licensing and has presented at business events, conferences, and trade shows worldwide. His book Hidden Wealth: The Money Making Power of Licensing was published in 2019. His work has been featured in the Licensing Journal and Intellectual Property Magazine.

Medical Technology Power Rangers Batman Hidden Wealth (2019) Licensing Journal IP Magazine
Free 15-Minute Session

Let's Talk About Your MedTech IP

Schedule a private 15-minute strategy session with Rand Brenner to evaluate your medical technology IP and identify your best licensing pathway to market.

Assess your IP's licensing readiness and market positioning
Identify the right types of licensing partners for your technology
Get a clear, actionable starting point — free, no obligation
Schedule Your Free Session →

15 minutes · Free · No obligation · Via video call